ANELLODESIGN Trademark
ANELLODESIGN is a USPTO trademark filed by Ring Therapeutics, Inc.. Status: Abandoned.
Trademark Facts
| Mark | ANELLODESIGN |
|---|---|
| Serial Number | 97269150 |
| Status | Abandoned |
| Filing Date | 2022-02-16 |
| Mark Type | Word |
| Nice Classes | 009 (Electronics & Software), 042 (Software & IT) |
| Owner | Ring Therapeutics, Inc. |
| Attorney of Record | Christina M. Licursi |
| Prosecution Events | 32 |
| Latest Event | ABN6 on 2025-06-16 |
Goods & Services
Downloadable software for the discovery, capture, and analysis of data in the field of anelloviruses; downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical research and anellovirsues; downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; Product development for others in the field of biotechnology and development of pharmaceuticals and therapeutic agents; research and development of therapeutics related to the discovery, capture, and analysis of data in the field of anelloviruses; laboratory services for the discovery, capture, and analysis of data in the field of anelloviruses; providing online non-downloadable software for the discovery, capture, and analysis of data in the field of anelloviruses; providing temporary use of on-line non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical research and anelloviruses; providing temporary use of on-line non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic product